ASM Attends UN General AssemblyASM President, Susan Sharp, Ph.D., joined global leaders at the United Nations General Assembly in New York today in a historical meeting to focus on the commitment to fight AMR.
The American Academy of Microbiology recently announced seventy-three new Fellows, elected in recognition of their records of scientific achievement and original contributions that have advanced microbiology.
Certifying microbiologists for over 50 years, the National Registry of Microbiologists (NRM) has changed its name to the National Registry of Certified Microbiologists (NRCM). The new name better articulates the registry’s primary goal of certifying qualified microbiologists. To earn NRCM status, an individual must meet rigorous educational and experiential eligibility requirements and pass a comprehensive examination.
The February edition of News and Views, a publication of the American Academy of Microbiology, is available.
New Combination Therapy May Protect Against Implant-Associated MRSA Infections
(D. Baldoni, M. Haschke, Z. Rajacic, W. Zimmerli, A. Trampuz. 2009. Linezolid alone or combined with rifampin against methicillin-resistant Staphylococcus aureus (MRSA) in experimental foreign-body infection. Antimicrobial Agents and Chemotherapy, 53. 3: 1142-1148.) The study suggests that combination therapy using the antibiotics linezolid and rifampin may effectively treat drug-resistant MRSA implant-associated infections.
New Vaccine May Protect Against Campylobacter jejuni
(M.A. Monteiro, S. Baqar, E.R. Hall, Y. Chen, C.K. Porter, D.E. Bentzel, L. Applebee, P. Guerry. 2009. Capsule polysaccharide conjugate vaccine against diarrheal disease caused by Campylobacter jejuni. Infection and Immunity, 77. 3: 1128-1136.) The research shows that a new conjugate vaccine containing the capsule polysaccharides from two strains of Campylobacter jejuni, a major cause of bacterial diarrhea worldwide, provides protection against infection in mice and monkeys and may ultimately have human implications.
Compound Found in Plant Products May Offer New Treatment for Malaria
(P. Njomnang Soh, B. Witkowski, D. Olagnier, M. Nicolau, M. Garcia-Alvarez, A. Berry, F. Benoit-Vical. 2009. In vitro and in vivo properties of ellagic acid in malaria treatment. Antimicrobial Agents and Chemotherapy, 53. 3: 1100-1106.) Research findings suggest that ellagic acid, a compound found in plant products, may be effective against malaria and ultimately lead to new forms of treatment.
ASM Press announces the latest edition of an essential reference volume in one of the most dynamic and rapidly changing fields of clinical medicine. Covering novel viruses, pathogenesis, epidemiology, diagnosis, treatment, and prevention, Clinical Virology informs scientists and health care professionals about all the medically relevant aspects of this rapidly evolving field.
The 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) will be held in San Francisco, California, September 12 – 15, 2009. Abstract submission is open through May 1. The Call for Abstracts is available on-line.